Ionis Feels Effect of FDA’s Ruling

The U.S. Food and Drug Administration on Aug. 26 declined to approve Waylivra, a drug from Ionis Pharmaceuticals targeting an ultra-rare disease.

Clinical Research Organization Prosciento Names New COO

Dr. Linda Morrow, COO since 2009, becomes Prosciento's chief medical officer.

Illumina System Gains Approval in China

Illumina notched approval from the China National Drug Administration to market and sell its MiSeqDx sequencing system to hospitals and other medical institutions throughout the country.

Althea Expands Into New Manufacturing Space

Ajinomoto Althea Inc., the biopharmaceutical contract development and manufacturing company, has opened a 57,000-square-foot manufacturing facility in Sorrento Mesa.

Biotechs Find Favorable Conditions in UTC As An Amenity-Rich Alternative to Torrey Pines

When scouting where to consolidate San Diego operations, Takeda Pharmaceuticals put together a checklist. Most pressing: a plot that could accommodate 300 employees, near research institutions and other life science companies.

Tease photo

Ionis Pharmaceuticals’ Stock Drops After FDA Letter

Shares of Ionis Pharmaceuticals and spinout Akcea Therapeutics kept falling Tuesday morning after a U.S. Food and Drug Administration division failed to sign off on their drug Waylivra.

J. Craig Venter Institute Calls for Dismissal of Lawsuit

The J. Craig Venter Institute filed a motion to dismiss a lawsuit alleging that its CEO, J. Craig Venter, took trade secrets from former employer Human Longevity.

Rakuten Aspyrian Raises $150 Million in Series C Round

Rakuten Aspyrian hauled in a $150 million Series C round as the company’s lead cancer candidate moves into a final-stage trial.

Viterbi Gives $50M to UC San Diego

Businessman, academic and philanthropist Andrew J. Viterbi has given $50 million to UC San Diego to support its ophthalmology programs.

Dthera Sciences Nabs FDA Breakthrough Designation

Dthera Sciences’ device intended for Alzheimer’s patients has received a breakthrough designation that will speed regulatory review.

Kane Named CEO of UC San Diego Health Physicians

Dr. Christopher Kane will lead the charge to expand primary care access, among other goals, in new roles as dean of clinical affairs for UC San Diego School of Medicine and CEO of UC San Diego Health Physicians.

Dexcom Buys TypeZero Technologies

San Diego’s Dexcom has gained additional diabetes management technology by acquiring TypeZero Technologies. Deal terms were not disclosed.

Wave of Investment Has Life Sciences Swimming in Cash

Cash is pouring into early-stage San Diego life sciences, with 2018 shaping up as a banner year, according to observers.

Tease photo

Rady Children’s Appoints New CEO

Dr. Patricio “Patrick” A. Frias has been named as the new president and CEO of Rady Children’s Hospital and Health Center.

Tri-City to Reconsider Suspension of Mental Health Unit

The Tri-City Healthcare District board will soon reconsider a decision to suspend operations of the center’s inpatient Behavioral Health Unit and Crisis Stabilization Unit.